Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francine M Gregoire

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
BMC Cardiovascular Disorders|November 1, 2015
Left ventricular diastolic dysfunction in nonhuman primate model of dysmetabolism and diabetesHaihua Gu, Yongqiang Liu, Shuang Mei, et al.
Molecular Endocrinology (Baltimore, Md.)|April 25, 2009
MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edemaFrancine M Gregoire, Fang Zhang, Holly J Clarke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2022
Evaluation of cytosine base editing and adenine base editing as a potential treatment for alpha-1 antitrypsin deficiencyMichael S Packer, Vivek Chowdhary, Genesis Lung, et al.
Nature Communications|November 10, 2024
Base-editing corrects metabolic abnormalities in a humanized mouse model for glycogen storage disease type-IaIrina Arnaoutova, Yvonne Aratyn-Schaus, Lisa Zhang, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
BMC Cardiovascular Disorders|November 1, 2015
Left ventricular diastolic dysfunction in nonhuman primate model of dysmetabolism and diabetesHaihua Gu, Yongqiang Liu, Shuang Mei, et al.
Molecular Endocrinology (Baltimore, Md.)|April 25, 2009
MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edemaFrancine M Gregoire, Fang Zhang, Holly J Clarke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2022
Evaluation of cytosine base editing and adenine base editing as a potential treatment for alpha-1 antitrypsin deficiencyMichael S Packer, Vivek Chowdhary, Genesis Lung, et al.
Nature Communications|November 10, 2024
Base-editing corrects metabolic abnormalities in a humanized mouse model for glycogen storage disease type-IaIrina Arnaoutova, Yvonne Aratyn-Schaus, Lisa Zhang, et al.
Pageof 2